Heartburn medicine Zantac could be a possible cancer-causing drug, FDA carries on its investigation

It was stated by the health officials of the United States that they are conducting investigations on low levels of the possibly hazardous contaminant in the widespread heartburn medication Zantac, as well as, associated generic drugs. For the time being, the patients could continue using their medications, stated the Food and Drug Administration. Statements were passed by the agency saying that it has detected a potential chemical in the m....